Ocular Therapeutix, Inc.
OCUL
$11.04
$0.282.60%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -8.90% | 8.06% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.90% | 8.06% | |||
| Cost of Revenue | -3.21% | 2.09% | |||
| Gross Profit | 1.12% | -0.06% | |||
| SG&A Expenses | 5.17% | 3.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.28% | 2.64% | |||
| Operating Income | -1.55% | -1.56% | |||
| Income Before Tax | 6.86% | -2.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.86% | -2.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.86% | -2.37% | |||
| EBIT | -1.55% | -1.56% | |||
| EBITDA | -1.31% | -1.52% | |||
| EPS Basic | 23.16% | 3.95% | |||
| Normalized Basic EPS | 23.19% | 3.99% | |||
| EPS Diluted | 23.68% | 3.28% | |||
| Normalized Diluted EPS | 23.19% | 3.99% | |||
| Average Basic Shares Outstanding | 21.21% | 6.56% | |||
| Average Diluted Shares Outstanding | 21.21% | 6.56% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||